Stay updated with breaking news from Neuron group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
+44 (0)20 7933 8780 or [email protected] Paul McManus, Alice Woodings
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop off the shelf stem cell treatments, without the need for immunosuppressive drugs. The Company s lead cell therapy candidate is in clinical development for the blindness-causing disease, retinitis pigmentosa. ReNeuron is also advancing its proprietary exosome technology platform as a potential delivery system for drugs that treat diseases of the brain. he Company also has the ability through its conditionally immortalised induced pluripotent stem cell (iPSC) platform to make any tissue cells of choice; in-house programmes are focused on treatments for blood cancers and diabetes. ....
Search jobs 12-Mar-2021 Exosome Therapeutic Industry 2021 Share, Top Manufacturers, Market Size, Segmentation, Types, Application, Technology, Trends and Forecasts to 2027 DBMR started a new business research with title Global Exosome Therapeutic Market Study Forecast till 2027.This Global Exosome Therapeutic market report brings data for the estimated year 2021 and forecasted till 2027 in terms of value (US$ MN). The market report also focuses on market size, growth, share, segments, manufacturers, and technologies, key trends, market drivers, challenges, standardization, deployment models, opportunities, future roadmap and global major leading industry players with information. The report on the Exosome Therapeutic market is an exclusive and deep study that delivers a comprehensive overview of the industry contains the recent trends and future scopes of the market in terms of product and services. The study is condu ....